Logo 1 Logo 2

Clinical Trial Details

Trial ID: L1707
Source ID: NCT03281538
Associated Drug: Cr845
Title: Extension Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Acronym:
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT03281538/results
Conditions: Uremic Pruritus
Interventions: DRUG: CR845
Outcome Measures: Primary: Number of Participants With AEs, Assessed by physical examination, monitoring of adverse events, vital signs and laboratory assessments, Up to 52 weeks |
Sponsor/Collaborators: Sponsor: Cara Therapeutics, Inc.
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 288
Study Type: INTERVENTIONAL
Study Designs: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2017-08-14
Completion Date: 2020-02-11
Results First Posted: 2021-10-14
Last Update Posted: 2021-10-14
Locations: Cara Therapeutics Study Site, Chula Vista, California, 91990, United States|Cara Therapeutics Study Site, El Centro, California, 92243, United States|Cara Therapeutics Study Site, Long Beach, California, 90813, United States|Cara Therapeutics Study Site, Northridge, California, 91324, United States|Cara Therapeutics Study Site, Denver, Colorado, 80230, United States|Cara Therapeutics Study Site, Hollywood, Florida, 33024, United States|Cara Therapeutics Study Site, Tampa, Florida, 33614, United States|Cara Therapeutics Study Site, Winter Park, Florida, 32789, United States|Cara Therapeutics Study Site, Albany, Georgia, 31701, United States|Cara Therapeutics Study Site, Augusta, Georgia, 30909, United States|Cara Therapeutics Study Site, Meridian, Idaho, 83642, United States|Cara Therapeutics Study Site, Springfield, Massachusetts, 01107, United States|Cara Therapeutics Study Site, Roseville, Michigan, 48066, United States|Cara Therapeutics Study Site, Kansas City, Missouri, 64131, United States|Cara Therapeutics Study Site, Albuquerque, New Mexico, 87109, United States|Cara Therapeutics Study Site, Gallup, New Mexico, 87301, United States|Cara Therapeutics Study Site, Mineola, New York, 11501, United States|Cara Therapeutics Study Site, Ridgewood, New York, 11385, United States|Cara Therapeutics Study Site, Bethlehem, Pennsylvania, 18017, United States|Cara Therapeutics Study Site, Knoxville, Tennessee, 37920, United States|Cara Therapeutics Study Site, El Paso, Texas, 79902, United States|Cara Therapeutics Study Site, San Antonio, Texas, 78202, United States|Cara Therapeutics Study Site, San Antonio, Texas, 78221, United States|Cara Therapeutics Study Site, San Antonio, Texas, 78229, United States|Cara Therapeutics Study Site, Saint George, Utah, 84790, United States|Cara Therapeutics Study Site, Wauwatosa, Wisconsin, 53326, United States|Cara Therapeutics Study Site, San Juan, 00926, Puerto Rico
URL: https://clinicaltrials.gov/show/NCT03281538

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress